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Smallpox was formally declared as eradicated in 1979. Smallpox is 
the only infectious disease of humans that has ever been eradicated. 
Poliomyelitis has been eliminated from three of the six World Health 
Organization (WHO) regions although not all countries within those 
regions always meet the elimination criteria. Elimination criteria 
for measles are being discussed. We use poliomyelitis and measles 
as examples to illustrate our assertion that the current approach to 
documenting measles elimination relies too heavily on criteria for 
surveillance quality, disadvantaging countries with long established 
and relatively inflexible surveillance systems. We propose an 
alternative approach to documenting measles elimination, with the 
two key criteria being molecular evidence to confirm the lack of a 
circulating endemic genotype for at least one year and maintenance 
of 95% coverage of one dose of measles-containing vaccine, with 
an opportunity for a second dose. Elimination status should be 
reviewed annually. We suggest four principles that should guide 
development of final criteria to document measles elimination: 
countries that have eliminated measles should be able to meet 
the elimination criteria; quality surveillance criteria are necessary 
but not sufficient to define elimination; quality surveillance criteria 
should be guided by elimination criteria, not the other way around; 
and elimination criteria should not differ between the WHO regions 
without good reason.
Introduction
Smallpox is the only infectious disease of humans that has 
been successfully eradicated, with a formal declaration made in 
December 1979 [1]. At this time, eradication was defined by the 
World Health Organization (WHO) as the absence of circulating 
wild virus, manifested as no cases in a defined geographic area 
for a period of at least three years after cessation of vaccination. 
 In 1988, the World Health Assembly resolved to eradicate 
polio globally by the year 2000. The eradication of poliovirus 
requires zero cases of poliomyelitis due to wild poliovirus for three 
years, high quality disease surveillance which meets international 
standards, and demonstrated capacity of the countries to detect, 
report and respond to imported polio cases, including those 
caused by vaccine-derived polioviruses. In addition, laboratory 
stocks need to be contained and safe management of polio vaccine 
manufacturing sites assured before the world can be certified as 
polio-free [2].  Eradication by 2000 was not achieved, but in 2009, 
polio remained endemic in only four countries.  The eradication of 
polio is now seen as an achievable goal within the next four or five 
years [3], although some commentators question even this timeline.
More recently, goals for progress towards measles elimination, 
rather than eradication, have been proposed by a number of 
WHO regions, including the European and Western Pacific 
Regions. Member states of the Western Pacific Region, which 
include Australia, have resolved to eliminate measles by 2012 
[4]. The European region aims to eliminate measles by 2010 [5]. 
Elimination is defined as the sustained interruption of transmission 
of endemic virus within a defined geographic region. Sustained 
endemic transmission is defined as an outbreak of more than 
100 cases or ongoing transmission with a measles genotype of 
identical sequence for more than three months [6]. Elimination 
does not imply that there is no virus within the defined region 
(this is eradication), but that the transmission of endemic virus 
has been eliminated [6].
We aim to review the criteria used to define polio eradication 
and measles elimination in the Australian, European and other 
international context and discuss alternatives to the criteria for the 
documentation of the elimination of measles.
Australia and polio 
As a member state of the Western Pacific Region, Australia was 
declared free of circulating endemic poliovirus only in October 
2000 [7], although the last case of endemic poliovirus infection 
probably occurred around 30 years earlier [8]. The cornerstone of 
the documentation of polio-free status is surveillance of patients 
presenting with acute flaccid paralysis (AFP), the most common 
clinical presentation of acute poliovirus infection, although such 
cases represent only between one in 100 and one in 1,000 cases 
of infection [9].
The WHO criteria for adequate AFP surveillance are 
• An annual notification rate of one case presenting with acute 
flaccid paralysis per 100,000 population aged under 15 years, 
• Collection of two stool samples 24 hours apart within 14 days 
of symptom onset from 80% of notified cases, 
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• Testing of stool samples in a WHO-accredited laboratory to 
exclude wild poliovirus as the cause of the patient’s symptoms 
[9]. 
Although countries where polio had been endemic in the recent 
past have met these criteria, Australia has consistently failed to do 
so. Of the 14 years that AFP surveillance has been undertaken in 
Australia, the targets for case ascertainment have been achieved 
in only five years (Figure) and the criteria for stool collection have 
never been met [10]. 
We have previously shown, at least for the state of Victoria and 
by inference for other Australian states, that it was not a lack of 
AFP cases that led to notification rates below the WHO target, but 
incomplete notification of cases [11]. Despite not meeting the WHO 
AFP surveillance criteria for the maintenance of the documentation 
of polio-free status, Australia, as a member state of the polio-free 
Western Pacific Region, is nonetheless acknowledged to have no 
circulating wild poliovirus.
Australia and measles
We have previously reviewed the body of evidence to demonstrate 
that Australia has eliminated the transmission of endemic measles 
[12]. Although we acknowledged that measles virus was still 
detected in Australia, we argued that the transmission of endemic 
measles virus has been eliminated, based on criteria we compiled 
using the evidence for Australia [12]:
• Absence of an endemic genotype since 1999, 
• High proportion of cases imported or linked to an imported case 
since 1999, 
• Containment of outbreaks without the re-establishment of a 
specific genotype since 1999, 
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Australia’s documentation of measles elimination compared with the criteria proposed by the WHO Western Pacific Regional 
Office, September 2007 
Western Pacific Regional Office criterion for progress towards measles 
elimination
Criterion status in Australia 
1. Confirmed measles cases <1 per million Met in 2005 and 2007; not met in 2006 or 2008
2. Reported suspected measles cases >2 per 100,000 Not available at a national level; met in the state of Victoria since 1999
3. At least 80% of districts reporting >1 per 100,00 suspected cases Data not collected at a national level 
4. At least 80% of cases investigated within 48 hours Data not available at a national level
5. At least 80% of cases with adequate blood samples collected Data not available at a national level
6. At least 80% of cases with laboratory results within seven days Data not available at a national level
7. At least 80% of clusters with samples for virus isolation Data not available at a national level
8. Two-dose MCV coverage >95% MCV1 >95% and MCV2 >90%
9. At least 80% of clusters with <10 cases Data not available at a national level
10. Absence of endemic measles virus No endemic measles virus since 1999
MCV: measles-containing vaccine; WHO: World Health Organization.
Adapted from Heywood et al. [12].
T a b l e  2
Alternative criteria for the documentation of measles elimination  
Criterion Justification
The absence of an endemic measles genotype for at least 12 months
Based on the criterion by which England and Wales declared the re-establishment of 
endemic viral transmission [18].
One dose MCV coverage >95% with the opportunity for a second dose. 
One dose of MCV administered at the age of 12 months with coverage >95% was modelled 
to be more likely to maintain elimination status than a two-dose regime [19]. The 
failure to maintain high measles vaccine coverage led to measles becoming again 
endemic in England and Wales [18].
MCV: measles-containing vaccine.
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• Maintenance of an effective reproductive number for measles 
<1 since 1999, 
• Serological evidence of population immunity >90% since 2002, 
• Consistently high two-dose vaccination coverage since 2004: 
>95% for the  first dose of measles-containing vaccine (MCV) 
and >90% for the second dose of MCV, 
• <1 notified confirmed endemic case per million population since 
2005. 
We examined Australia’s ability to meet the criteria proposed 
by the Western Pacific Regional Office (WPRO) in 2007 for the 
documentation of progress towards measles elimination in member 
states of the Western Pacific Region (Table 1) [12,13]. 
The first WPRO criterion requires a national incidence of less than 
one confirmed measles case per million population. A confirmed 
case includes laboratory-confirmed cases, cases epidemiologically 
linked to a laboratory-confirmed case, or clinically confirmed cases; 
imported cases are excluded. In Australia, national surveillance data 
are not adequate to demonstrate the proportion of cases that are 
imported. In both 2005 and 2007, less than one case per million 
was reported in Australia, inclusive of imported cases. However, 
an importation leading to a widespread outbreak in 2006 resulted 
in a notification rate exceeding six cases per million population. 
Cases in 2008 also exceeded one case per million population. We 
are unable to quantify the number of confirmed measles cases 
in 2006 and 2008 that were not imported or directly related to 
importation [14]. 
In the first quarter of 2009, 78 cases of measles were 
notified in Australia, of which 17 were related to importation 
[15]. Large outbreaks occurred in Queensland and Victoria and 
smaller outbreaks occurred in other states. In the three months 
from January to March alone, the number of indigenous cases 
exceeded an annual notification rate of one per million inhabitants. 
However, extensive case follow-up and genotyping confirmed that 
the outbreaks were due to several different genotypes (D4, D8, D9 
and H1) and that no one genotype has been circulating for more 
than 12 months. 
The next six WPRO criteria relate to setting surveillance 
standards for suspected case investigation. Australia is unable to 
meet any of these criteria (Table 2). The final three criteria refer 
to vaccine coverage (≥95% two-dose MCV coverage), proving that 
80% of outbreaks have fewer than 10 cases and demonstrating the 
absence of an endemic measles genotype. Australia meets only the 
third of these criteria. However, in addition to the WPRO criteria, 
Australia has demonstrated a measles immunity exceeding 90% in 
the population in serological surveys [12], and a number of disease 
modelling studies have consistently estimated that the reproductive 
number for measles was less than one in a number of studies from 
Australia, indicating that endemic measles transmission cannot 
be sustained [12]. 
Measles elimination in other countries
In order of the year of declaration, nine countries – Finland, 
Cuba, England and Wales, Brazil, Mexico, Canada, the United 
States (US), South Korea and Australia – have publicly declared 
measles elimination using a variety of criteria (listed in Table 2 
of the paper by Heywood et al. [12]). However, unlike the other 
countries in this list, the Australian government has not formally 
ratified the declaration of measles elimination in Australia. The 
mode and median number of the 10 WPRO criteria that these 
countries satisfied was two (range: one to eight). South Korea, 
which satisfied eight of the 10 criteria, and Australia, which 
satisfied only two, are the only two nations in the Western Pacific 
Region whose declaration might be constrained by WPRO criteria. 
Finland, which has remained measles-free for 25 years, reports only 
the two criteria of low incidence and high vaccine coverage [16].
It is clear that disease elimination cannot be declared in the 
absence of high quality laboratory-enhanced surveillance. Reflecting 
this, the WPRO criteria for progress towards measles elimination 
include a number of specific laboratory indicators for high quality 
surveillance. In countries such as England and Wales, the US and 
Australia, specific WHO performance indicators for surveillance 
are difficult to satisfy. These countries were approaching measles 
elimination prior to the publication of the WHO elimination criteria, 
and development of national surveillance systems preceded 
the smallpox and polio eradication programmes. Collating and 
summarising surveillance data from different state and local 
sources at a national level is often difficult. Some developed 
countries such as the US, did not attempt to justify their polio-
free status through AFP surveillance [2]. Surveillance systems in 
these countries were established outside the WHO framework, and 
do not have routine mechanisms to capture the surveillance process 
data specified by the WHO and reflected in the WPRO guidelines 
for the documentation of the eradication of polio or the elimination 
of measles. England and Wales declared measles elimination in 
2003 prior to the establishment of formal elimination criteria [17] 
The laboratory-enhanced measles surveillance system of England 
and Wales does not meet all the surveillance benchmarks specified 
by WPRO criteria. Despite this, the system rapidly detected the 
re-establishment of endemic measles in England and Wales in 
2008 [18]. Furthermore, the experience of England and Wales 
demonstrates the critical fact that elimination is an ongoing 
task. While wild virus is circulating elsewhere, vaccine coverage 
needs to remain high to prevent the re-establishment of sustained 
transmission of measles virus. 
Reviewing the evidence which England and Wales used to 
declare elimination before acknowledging the re-establishment of 
endemic measles transmission illustrates the relative importance 
of elimination criteria [17,18] Measles elimination was declared 
in England and Wales using the following evidence [17], with the 
relevant WPRO criteria in brackets:
• MCV1 coverage of over 90% until 1998 (WPRO criterion: two-
dose coverage at least 95%), 
• Average number of measles cases of 1.8 per million inhabitants 
per year 1995-2001 (WPRO criterion: <1/million/year), 
• Small number of large clusters, four clusters with 10-24 cases 
and four clusters with 25 or more cases (WPRO criterion: ≥80% 
of outbreaks or transmission foci with <10 cases), 
• 23% of sporadic cases and 43% of clusters linked to a known 
imported case (no specified WPRO criterion), 
• Suspected measles case identification rate  ca. 4.4 per 100,000 
per year (WPRO criterion: >2/100,000) with 66% tested (WPRO 
criterion: >80% tested), 
• Wide variety of genotypes with absence of previous endemic 
genotype (WPRO criterion: no endemic genotype), 
• Effective measles reproductive number estimated as 0.5-0.7 by 
a variety of methods (no specified WPRO criterion). 
England and Wales, as part of the WHO European region, are not 
bound by the WPRO criteria for assessing progress towards measles 
elimination, but other WHO regions are proposing similar criteria. 
The WPRO criteria are used here to illustrate the comparison 
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of evidence for elimination with published criteria for assessing 
progress towards elimination required in one WHO region. Moreover, 
it is reasonable to expect that a country that has eliminated measles 
should satisfy criteria assessing the progress towards elimination. 
The interim criteria from the WHO Regional Office for Europe that 
would guide member states in declaring elimination [5] include 
the following:
• Vaccination coverage: achieving and maintaining at least 95% 
coverage with MCV1 and MCV2 in all districts and nationally; 
• Outbreak size: At least 80% of outbreaks should have less than 
10 confirmed measles cases; 
• Incidence: Achieving a measles incidence of less than one 
confirmed case per million population per year, excluding cases 
confirmed as directly imported; 
• Endemic measles virus strain(s):  zero cases of measles caused 
by an endemic strain for at least 12 months, i.e. evidence of the 
absence of endemic transmission by demonstrating zero cases 
of measles or zero cases with identical genotype sequence over 
a period of 12 months. 
Guidelines for measles elimination criteria in the European 
region are currently in late draft form, but a recently published 
review of progress towards measles elimination in Europe confirms 
the inclusion of the vaccine coverage and measles incidence criteria 
[5]. A number of surveillance criteria have also been added to the 
elimination criteria:
• 100% of member states should report monthly to WHO on 
measles cases; 
• 80% of member states should submit at least 80% of case-
based reports each month, and submit at least 80% of reports 
on time. 
When declaring measles elimination in 2003, England and 
Wales did not satisfy the criteria related to vaccine coverage or 
measles incidence. In addition, the surveillance criteria were not 
reported at the time.
Measles elimination criteria: an alternative approach
The experience of all countries that have eliminated measles 
highlights a general problem with WHO criteria for progress towards 
elimination. It is not possible for most countries that have clearly 
eliminated measles to meet the criteria for progress towards 
elimination. This is a strange anomaly. 
Since elimination criteria are yet to be finalised, we suggest 
that consideration be given to documenting measles elimination 
using only two criteria:
• The absence of an endemic measles genotype for at least 12 
months, 
• One-dose MCV coverage of at least 95% with an opportunity 
for a second dose. 
In conjunction with suitable surveillance standards, these criteria 
could also be used for assessing progress towards elimination. 
Justification for these criteria is presented in Table 2. 
Table 3 evaluates the two proposed alternative criteria for 
measles elimination against evidence presented by the nine 
countries declaring elimination. All countries reported on measles 
vaccine coverage targets and all except England and Wales satisfied 
this criterion. Only Finland and Mexico did not provide evidence of 
the absence of circulating genotypes, but would without doubt be 
able to report on these criteria on an annual basis.
Although not absolutely necessary, these criteria could be 
supported by the demonstration of a reproductive number of less 
than one for measles and the estimation of at least 90% population 
immunity. While low measles notification rates are important, we 
believe that a number of confirmed cases under one per million is 
T a b l e  3
Assessment of alternative criteria for measles elimination by countries declaring measles elimination
Country declaring measles elimination and year of declaration
Alternative elimination criteria
Absence of an endemic measles genotype for 
at least 12 months
One-dose MCV* coverage of at least 95% 
plus opportunity for second dose
Finland, 1994 Not reported >97% two-dose coverage
Cuba, 1998 Reported absence of circulating virus 
One-dose coverage 98% with catch-up 
campaigns
England and Wales, 2003 Variety of circulating genotypes confirmed MCV1 coverage >90%; MCV2 introduced in 1996
Brazil, 2003 No endemic genotype >95% two-dose coverage since 1997
Mexico, 2004 Not reported
>95% coverage at age 1-6 years since 1996; 
>97% coverage at age 6-10 years since 1999
United States, 2004 No endemic genotype
>90% coverage at age 19-35 months; 98% 
coverage at school entry; >92% of school 
children immune
Canada, 2004 No endemic genotype since 1998 MCV1 coverage >95%; MCV2 introduced in 1996
Republic of Korea, 2006 No endemic genotype
>95% two-dose coverage; 93% of school 
children immune
Australia, 2008 (declaration not endorsed by national authority) No endemic genotype since 1999 MCV1 coverage >95% MCV2 coverage >90%
MCV: measles-containing vaccine.
Adapted from Heywood et al. [12]. 
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not a necessary requirement for elimination to be declared, because 
of residual susceptibility in young adults documented in a number 
of countries [20-22] and because there is an increased risk of 
transmission within susceptible groups that may have religious 
or other objections to vaccination. It is, however, necessary to 
demonstrate that an importation of a specific measles genotype 
into a susceptible subgroup does not result in transmission of that 
measles genotype in the wider population over a period of more than 
12 months, as has occurred in England and Wales. In Australia, 
22 confirmed cases notified in a year will exceed the threshold 
of one confirmed case per million. Small outbreaks among young 
adults resulting from importations have regularly resulted in higher 
numbers of annual cases during the period when there was no 
endemic measles genotype [23]. These importations have not led to 
the re-establishment of endemic measles transmission in Australia.
Surveillance criteria are important for the documentation of the 
elimination of endemic measles transmission. Using the proposed 
alternative elimination criteria, it is only critical that cases and 
clusters are identified and that a suitable specimen is sent to a 
WHO-accredited laboratory for genotype identification. As already 
recommended by WHO, all suspected cases of measles should have 
a serum sample sent to an accredited laboratory for testing measles 
IgM by a commercial enzyme-linked immunosorbent assay. We 
further suggest that a suitable specimen for genotyping, preferably 
a nose/throat swab [24], should be collected from all serologically 
confirmed cases that are not part of clusters and from a minimum 
of two cases at the start and two cases at the end of any identified 
cluster.  Placing the emphasis on identifying the absence of an 
endemic genotype over a 12-month period requires efforts to be 
focussed on genotype capture, rather than performing individual 
serological tests within a nominated time. If using the alternative 
criteria suggested here, it would not be necessary to confirm a case 
within seven days as is specified in the WPRO criteria. However it 
would still be necessary to collect a specimen suitable for genotype 
identification not more than two weeks after rash onset [24]. When 
countries do not have a national laboratory that is able to perform 
measles genotyping, appropriate specimens could be referred to a 
regional laboratory for genotyping, with all results reported to the 
WHO in order to monitor international transmission patterns [25].
The WPRO criteria related to outbreaks (criteria 7 and 9, Table 
1) can be subsumed into the single criterion of complete absence of 
endemic measles genotype (criterion 10). While it may be difficult 
to find all cases that are not part of a cluster, all countries with an 
active surveillance system should be able to recognise clusters. 
In Finland, where measles has been eliminated for 25 years, it is 
noted that ‘some sporadic imported cases may have escaped our 
attention, but clusters of secondary cases would almost certainly 
have been detected had they occurred’ [16]. 
Conclusions
Despite best intentions and a considerable amount of effort, 
Australia has not been able to maintain WHO AFP surveillance 
criteria for the documentation of polio eradication [26]. However, it 
is accepted that Australia is free of circulating wild poliovirus, the 
single most important criterion for eradication. We have provided 
evidence to support our claim that Australia has eliminated measles 
transmission, but cannot satisfy the criteria for documenting 
progress towards elimination promulgated by the WHO WPRO. 
Neither has this evidence resulted in a formal declaration of 
measles elimination in Australia. Incidentally, we note that the 
WHO position on the status of measles elimination in Australia 
is not completely clear. The WHO document Global measles and 
rubella laboratory network – update published in 2005 [27], prior 
to presentation of evidence for measles elimination in Australia, 
acknowledged measles elimination in Australia. Map 1 in that 
document states that ‘Measles has been eliminated from the 
Western Hemisphere and Australia’ [emphasis added] and did not 
include any countries from the western hemisphere or Australia on 
the map. The document also noted that multiple genotypes had 
been detected from imported cases [27]. However, a more recent 
WHO publication suggests that the Republic of Korea is the first 
and only country in the Western Pacific Region to have achieved 
elimination [28].
We believe it is appropriate to separate criteria for the 
documentation of measles elimination from surveillance 
performance and laboratory accreditation. We suggest it may 
be worth considering only two criteria for the documentation of 
measles elimination with an annual review of elimination status. 
Finally we suggest there are four principles that should guide the 
development of formal documentation of measles elimination:
1. Elimination criteria should be able to be met by countries 
that have eliminated measles;
2. Quality surveillance criteria are necessary but not sufficient 
to define elimination;
3. Quality surveillance criteria should be guided by elimination 
criteria, not the other way around;
4. Without good reason, elimination criteria should not differ 
by WHO region.
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